Small Cell Lung Cancer

  • Michael WahlEmail author
  • Adam Garsa


This chapter will discuss the workup, staging, and management of small cell lung cancer, with an emphasis on radiation therapy treatments and published data.


Small cell lung cancer Radiation therapy Chemotherapy Prophylactic cranial irradiation 



We thank R. Scott Bermudez MD, Brian Missett MD, and Daphne A. Haas-Kogan MD for their work on the prior edition of this chapter.


  1. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med. 1999;341:476–84.CrossRefGoogle Scholar
  2. De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, et al. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol. 2006a;17:543–52.CrossRefGoogle Scholar
  3. De Ruysscher D, Pijls-Johannesma M, Bentzen S, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small cell lung cancer. J Clin Oncol. 2006b;24:1057–63.CrossRefGoogle Scholar
  4. Faivre-Finn C, Snee M, Ashcroft L, et al. CONVERT: an international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS). J Clin Oncol. 2016;34. (suppl; abstr 8504).Google Scholar
  5. Jeremic B, Shibamoto Y, Nikolic N. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol. 1999;17:2092–9.CrossRefGoogle Scholar
  6. Komaki R, Paulus R, Ettinger DS, Videtic GM, Bradley JD, Glisson BS, Choy H. A phase II study of accelerated high-dose thoracic radiation therapy (AHTRT) with concurrent chemotherapy for limited small cell lung cancer: RTOG 0239. J Clin Oncol. 2009;27:7s (suppl; abstr 7527).Google Scholar
  7. Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 2203-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol. 2009;10:467–74.CrossRefGoogle Scholar
  8. National comprehensive cancer network clinical practice guidelines in oncology: small cell lung cancer. Available at: Accessed 31 Aug 2016.
  9. Pignon JP, Arriagada A, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;3:1618–24.CrossRefGoogle Scholar
  10. Pijls-Johannesma M, De Ruysscher D, Vansteenkiste J, et al. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials. Cancer Treat Rev. 2007;33(5):461–73.CrossRefGoogle Scholar
  11. Shirvani SM, Komaki R, Heymach JV, et al. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;82(1):e91–7.CrossRefGoogle Scholar
  12. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357:664–72.CrossRefGoogle Scholar
  13. Slotman B, van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer. Lancet. 2015;385:36–42.CrossRefGoogle Scholar
  14. Tsuchiya R, Suzuki K, Ichinose Y, et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg. 2005;129(5):977–833.CrossRefGoogle Scholar
  15. Turrisi AT III, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265–71.CrossRefGoogle Scholar
  16. Van Loon J, De Ruysscher D, Wanders R, et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2010;77(2):329–36.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Radiation OncologyUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations